A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers

NCT03588130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Leg Ulcer

Interventions

DRUG: EscharEx (5% EX-02 formulation)
DRUG: Gel Vehicle
DRUG: Non-surgical standard of care (NSSOC)

Sponsor

MediWound Ltd